Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

Labour MSP Paul Sweeney has claimed there is a wider breakdown in patient safety at Stobhill Hospital in Glasgow, after an NHS investigation was launched into elderly dementia patients being given ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

The results, along with other data, support further work to assess lithium's potential neuroprotective properties, the ...

Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.

Surviving cancer at a young age may come with an unexpected cost: faster aging at both the cellular and brain levels. Researchers found that survivors often show signs of being biologically older than ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the production of toxic amyloid beta peptides in the first place.

Numerous additional benefits of GLP-1 weight loss drugs continue to be discovered, and new research has found the blockbuster ...

When people struggle with anxiety and depression, the most effective approach is often to combine medication and ...

These new drugs have transformed research into new therapies. There are more clinical trials in Alzheimer’s than ever before. Studies indicate other pathways besides the amyloid protein that ...

Veterans and others who have suffered trauma and injuries are flocking to clinics around the world to take ibogaine. My own ...